1. P21 The evaluation of serum ferritin and trasferrin saturation in the diagnosis of haemochromatosis in an ethnically diverse population. (16th November 2010) Authors: Al-shamma, S; Khaled, S; Kennedy, P; Provan, A Journal: Gut Issue: Volume 59(2010)Supplement 2 Page Start: A20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P61 Bone mineral density loss in tenofovir treated Chronic Hepatitis B Virus (HBV) patients is a consequence of Vitamin D deficiency and not Tenofovir therapy. (6th September 2011) Authors: Gill, U S; Al-shamma, S; Burke, K; Ross, V; Marley, R T C; Kooner, P; Foster, G R; Kennedy, P T F Journal: Gut Issue: Volume 60:(2011)Supplement 2 Page Start: A28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PWE-144 Frax Score in the Assessment of Bone Mineral Density Changes in Tenofovir Treated Chronic Hepatitis B Patients. (4th June 2013) Authors: Gill, U S; Zissimopoulos, A; Al-shamma, S; Burke, K; McPhail, M; Barr, D; Ross, V; Kallis, Y; Kooner, P; Marley, R; Foster, G R; Kennedy, P T Journal: Gut Issue: Volume 62(2013)Supplement 1 Page Start: A190 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗